Back to Agenda
International Collaboration in Times of Public Health Crisis
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development, Bill and Melinda Gates Foundation, United States
International collaboration amongst regulators is important from the industry aspiration that it should suffice to develop one global dossier. In the wake of the Ebola crisis, and again during the current Zika event, regulators have and are demonstrating a willingness to find new and pragmatic ways of working together with industry with the ultimate goal of providing health care solutions which are in demand by society. Are there lessons learned that can be shared and discussed? Can the envelope be pushed even further?
Learning Objective : Describe the current state of cooperation amongst regulators during Public Health Emergencies; Identify the challenges faced by the stakeholders, Discuss lessons learned in addressing the challenges.
Speaker(s)
Jarbas Barbosa da Silva, MD, PHD
Assistant Director, Pan American Health Organization, United States
Crisis Management in the Face of a Global Health Pandemic: How Can We Leverage International Efforts?
Carmen T. Maher, BSN, MA, RN, RAC
Acting Assistant Commissioner for Counterterrorism Policy, OCS, OC, FDA, United States
Update From the FDA
Agnès Saint-Raymond, DrMed
Head of Division International Affairs, European Medicines Agency, Netherlands
Update from the EMA
Have an account?